Severe Irritant Contact Dermatitis Causing Skin Ulceration Secondary to a Testosterone Patch [PDF]
Testosterone replacement has undergone somewhat of a revolution in the past decade with the introduction of topical administration techniques, including patches and gels, as well as an increasing interest in the treatment of older men with low ...
Nathan Lawrentschuk, Neil Fleshner
doaj +8 more sources
A Comparison of a Novel Testosterone Bioadhesive Buccal System, Striant, with a Testosterone Adhesive Patch in Hypogonadal Males [PDF]
A novel delivery system has been developed for testosterone replacement. This formulation, COL-1621 (Striant), a testosterone-containing buccal mucoadhesive system, has been shown in preliminary studies to replace testosterone at physiological levels when used twice daily.
Márta Korbonits +8 more
openalex +5 more sources
FDA panel rejects testosterone patch for women on safety grounds [PDF]
A panel of advisers to the US Food and Drug Administration last week unanimously rejected an experimental testosterone patch as a treatment for women with sexual difficulties. Procter & Gamble, global manufacturer of household products, wants to market the patch to women who have become menopausal after ovarian surgery, are currently taking oestrogen,
Ray Moynihan
openalex +3 more sources
Local and Systemic Complications of Local Testosterone Patches and Gels
In recent decades, testosterone therapy has gained the attention of many researchers due to the increased demand for this modality worldwide, the increased average age of the different populations, and increased awareness of the potential uses of the modality in clinical settings.
Fahad Ahmed Al-Zahrani +10 more
openalex +3 more sources
Clinical Electrophysiology and Mathematical Modeling for Precision Diagnosis of Infertility [PDF]
How can cellular electrophysiology measurements and mathematical modeling of ionic channels help to identify pivotal targets in disease-related cell signaling?
Fernanda Carvalho Cavalari +7 more
doaj +2 more sources
Intrinsa: testosterone patch for low sexual desire in women [PDF]
Abstract Intrinsa, a transdermal testosterone patch, is licensed for women with hypoactive sexual desire disorder following bilateral oophorectomy or hysterectomy. Here, Steve Chaplin presents the clinical data relating to its efficacy and adverse effects, and Mr Panay comments on its role in therapy.
Steve Chaplin, Nick Panay
openalex +2 more sources
The testosterone patch for women [PDF]
Has the FDA discriminated against female sexual dysfunction by not endorsing Procter & Gamble's (P&G) Intrinsa? Has the pendulum swung so far to the right that drugs for sexual medicine receive undue scrutiny? Why is testosterone replacement therapy available for men, but not for women? How should the pharmaceutical industry proceed with future studies?
Sheryl A. Kingsberg
openalex +3 more sources
Indomethacin Abolishes the Potentiation Effect of Testosterone on the Relaxation Induced by Salbutamol and Theophylline by Directly Blocking the K+ Channels in Airway Smooth Muscle [PDF]
Indomethacin, ibuprofen, and acetylsalicylic acid (ASA) are non-steroidal anti-inflammatory drugs (NSAIDs) that inhibit prostaglandin (PG) synthesis. Previous studies in airway smooth muscle demonstrated that chronic exposure to testosterone (TES, 40 nM)
Jorge Reyes-García +4 more
doaj +2 more sources
ABSTRACT Aim To assess the amount of testosterone transferred from the abdominal application sites of a transdermal testosterone patch and a transdermal testosterone gel to cotton T-shirts worn for 24 hours during each treatment. Methods
Norman A. Mazer +5 more
openalex +3 more sources
Testosterone patches in the management of patients with mild/moderate systemic lupus erythematosus [PDF]
Androgen deficiency has been associated with the development of systemic lupus erythematosus (SLE). The aim of this study was to test the efficacy of testosterone patches vs placebo in female SLE patients with baseline mild-to-moderate disease activity in a randomized, double-blind, single-centre placebo-controlled trial.Patients received testosterone (
Caroline Gordon +6 more
openalex +3 more sources

